Galapagos NV ADR (GLPG) Stock Price, Quote & News

Company Profile

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic...

Industry: Biotechnology

Sector: Healthcare

Phone: 32 1 534 29 00

Fax: 32 1 534 29 01

Website: www.glpg.com

Address:

Generaal De Wittelaan L11 A3, Mechelen, Belgium

BillionerOfKing Feb. 28 at 4:38 AM

$GLPG Current Stock Price: $33.70 Contracts to trade: $32.5 GLPG Apr 17 2026 Call Entry: $1.80 Exit: $2.28 ROI: 26% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

erevnon Feb. 25 at 4:04 PM

RBC Capital maintains Galapagos $GLPG at Sector Perform and raises the price target from $32 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StocktwitsEarnings Feb. 23 at 10:25 PM

$GLPG Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $2.44 up 542.11% YoY • Reported revenue of $900.77M up 1093.16% YoY • Galapagos expects to be cash flow neutral to positive by the end of 2026, anticipating 2.78B to 2.85B in cash and financial investments at year-end. Restructuring cash costs are projected between 125M and 175M for 2026.

0 · Reply

OfficialStocktwitsUser Feb. 21 at 4:29 PM

$GLPG RSI: 48.97, MACD: 0.1751 Vol: 0.42, MA20: 34.07, MA50: 33.28 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 5 at 2:25 PM

$GLPG Current Stock Price: $34.62 Contracts to trade: $35.0 GLPG Feb 20 2026 Call Entry: $1.35 Exit: $1.86 ROI: 37% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

MandelbrotMarkets Feb. 4 at 9:55 AM

$GLPG biotech, European R&D

0 · Reply

hegdaom Jan. 27 at 12:18 PM

$CAPR $AUPH $GLPG $TARS

0 · Reply

potrero Jan. 27 at 11:18 AM

$CAPR Tang has a history of ruthlessness with zombie biotechs, as well as a history of validating successful growth stories ($AUPH, $GLPG, $TARS). CAPR is the latter, not the former. Given where Tang accumulated shares in each of the 3 other examples, it's a bullish indication for CAPR.

0 · Reply

mikesterz7 Jan. 6 at 12:03 AM

$GLPG The company had announced its intent to wind down the activities after a strategic review and sale process in October.

0 · Reply

StocktwitsNews Jan. 5 at 9:50 PM

Galapagos Stock Rises After Hours On Starting To Wind Down Cell Therapy Activities, Workforce Reduction $GLPG https://stocktwits.com/news/equity/markets/glpg-stock-rises-after-hours-on-starting-to-wind-down-cell-therapy-activities/cmxMCiBR4RL

0 · Reply

Galapagos Receives Transparency Notification from Bank of America

Mar 10, 2026, 5:01 PM EDT - 11 days ago

Market Cap	2.11B
Revenue (ttm)	1.26B
Net Income (ttm)	362.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	28.85%
Debt to Equity Ratio	0.00

Volume	134,800
Avg Vol	114,204
Day's Range	N/A - N/A
Shares Out	65.90M
Stochastic %K	18%
Beta	0.26
Analysts	Hold
Price Target	$31.83